Analyze Diet
Veterinary immunology and immunopathology2005; 106(1-2); 23-38; doi: 10.1016/j.vetimm.2005.01.003

Modulation of equine articular chondrocyte messenger RNA levels following brief exposures to recombinant equine interleukin-1beta.

Abstract: The effect of recombinant equine IL-1beta (EqIL-1beta) on steady-state mRNA levels of equine articular chondrocytes in high-density monolayer culture was investigated using a customized cDNA array analysis. Total RNA samples isolated from chondrocytes cultured in media alone or with the addition of 1 ng/ml EqIL-1beta for 1-, 3-, and 6-h durations of exposure were reverse transcribed, radiolabeled, and hybridized to a customized 380-target cDNA array. Means of duplicate log base 2 transformed hybridization signals were normalized to equine glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mean signal intensities. Differentially expressed transcripts were identified using a two-stage mixed linear analysis of variance model (Statistical Analysis Software, Cary, NC). A time-dependent pattern was observed in the number of transcripts increased > or =two-fold in response to EqIL-1beta after 1, 3 and 6h (1, 2 and 109 transcripts, respectively). At 6 h of EqIL-1beta stimulation, signal intensities for 88 cDNA targets with purported function in processes related to cell cycle, intracellular signaling, transcription, translation, extracellular matrix turnover, and inflammation, as well as a number of cDNAs lacking homology to previously reported cDNA sequences, were increased >two-fold and were associated with p<0.05. Principal component analysis identified a vector component ( approximately 10% of the total variation) corresponding to a potential EqIL-1beta co-regulation of cell cycle associated gene transcription. These results support and expand our existing comprehension of the complex role of IL-1 in modulated chondrocyte gene expression and suggest the involvement of specific target gene up-regulation and activation of downstream inflammatory cascade mediators. This study adds to the current understanding of the molecular events associated with an IL-1 induced inflammation and pathobiologic processes that may be associated with the development of equine osteoarthritis.
Publication Date: 2005-05-25 PubMed ID: 15910990DOI: 10.1016/j.vetimm.2005.01.003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examined how the protein equine interleukin-1beta (EqIL-1beta) impacts the gene expression levels of horse joint cells (chondrocytes), which might be related to the development of horse osteoarthritis. The study found that exposure to EqIL-1beta resulted in a time-dependent increase in expressed transcripts (gene products), especially associated with cell function and inflammatory processes.

Objectives and Methodology

  • This study was conducted to understand the impact of a recombinant protein, EqIL-1beta, on chondrocytes – the cells found in cartilage tissue in horse joints.
  • Cells were cultured in a media with and without EqIL-1beta for various periods. The researchers aimed to understand how this protein changes the cells’ genetic activity over time.
  • The scientists used a specialized cDNA array to analyze the cells’ activity. This means they were measuring the amount of messenger RNA (mRNA) – the intermediate step between genes and proteins they encode.
  • The fluctuating mRNA levels indirectly indicate changes in gene activity, allowing the researchers to observe any variations in behavior caused by the presence of EqIL-1beta.

Main Findings

  • The researchers detected a trend – over time, the number of transcripts that were upregulated (or produced in larger quantities) in response to EqIL-1beta increased.
  • After 6 hours, 88 particular gene sequences had increased expression levels by more than two-fold. These genes are associated with various cell functions, such as cell cycle, intracellular signaling, transcription, translation, extracellular matrix turnover, and inflammation.
  • Through principal component analysis, the researchers identified a potential co-regulation of EqIL-1beta and cell cycle related gene transcription.

Conclusions

  • The study broadens our understanding of how EqIL-1beta modulates gene expression in chondrocytes, especially with regards to inflammatory processes.
  • These insights suggest that IL-1 is involved, either directly or indirectly, in the development of inflammation that drives diseases like osteoarthritis in horse joints.
  • The study encourages further research on the molecular events underlying inflammation and joint disease development due to IL-1.

Cite This Article

APA
Takafuji VA, Howard RD, Ward DL, Sharova LV, Crisman MV. (2005). Modulation of equine articular chondrocyte messenger RNA levels following brief exposures to recombinant equine interleukin-1beta. Vet Immunol Immunopathol, 106(1-2), 23-38. https://doi.org/10.1016/j.vetimm.2005.01.003

Publication

ISSN: 0165-2427
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 106
Issue: 1-2
Pages: 23-38

Researcher Affiliations

Takafuji, V A
  • Orthopedic Research Laboratory, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA 24061-0442, USA.
Howard, R D
    Ward, D L
      Sharova, L V
        Crisman, M V

          MeSH Terms

          • Animals
          • Cartilage, Articular / drug effects
          • Cartilage, Articular / metabolism
          • Cells, Cultured
          • Chondrocytes / drug effects
          • Chondrocytes / metabolism
          • Gene Expression Regulation / drug effects
          • Horses / metabolism
          • Interleukin-1 / pharmacology
          • Interleukin-1 / physiology
          • Oligonucleotide Array Sequence Analysis / veterinary
          • RNA, Messenger / metabolism
          • Recombinant Proteins / pharmacology
          • Time Factors

          Citations

          This article has been cited 0 times.